Prediction: Buying Pfizer Stock Today Could Set You Up for Life

Pfizer is behind Eli Lilly and Novo Nordisk in the GLP-1 race, but long-term investors shouldn't count the company out.

Pharma stocks Pfizer, GSK offer defensive plays in an uncertain market: charts

Technical indicators for Pfizer and GSK have turned bullish.

Is Pfizer stock a buy after this win?

Good news has been scarce for this beaten-down drugmaker.

Pfizer: Why Wall Street Habitually Overestimates Target Price

TrumpRx/MFN pricing risks could pressure margins despite 9.3x fwd P/E, 6.27% dividend and pipeline gains. Read the latest ...

Pfizer: I'm Still Expecting A Massive Rebound

Pfizer Inc. Q4 shows post-COVID growth, Seagen-fueled oncology gains, and obesity upside. Click for this updated look at PFE ...

Pfizer Stock: Buy, Sell or Hold After Its 11% Rally So Far in 2026?

PFE stock is up 11% in 2026, but flat guidance, falling COVID sales and patent cliffs cloud its rebound story. Buy, sell or ...
24/7 Wall St.

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

Pfizer has quietly built momentum in 2026 and Guggenheim just raised its price target to $36 while reiterating a Buy rating.

Pfizer’s (PFE) Shares Up Since Jim Cramer Said “Pass”

Pfizer Inc. (NYSE:PFE) is one of Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks. Pfizer Inc. (NYSE:PFE) is one of the largest pharmaceutical companies in the world. It operates in the weight ...

Should You Avoid Pfizer? Here's the Key Risk to Watch

Pfizer has reached a turning point.

Jim Cramer Notes Pfizer (PFE) Has “Got a Lot of Stuff in the Pipeline”

Pfizer Inc. (NYSE:PFE) is one of Jim Cramer’s latest stock calls as he discussed the bullish AI investment thesis amid the ...
AOL

Here's Why Pfizer Stock Is Still a Buy

Pfizer (NYSE: PFE) got a huge boost during the coronavirus pandemic thanks to its COVID-19 vaccine. Since that point, however, investors have soured on the stock, which has lost more than half its ...